100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Hydroxide,N,O-Dimethylhydroxylamine Hydrochloride Solvents: Methanol; Rt; 30 Min,Rt; 1 H,80 °C 标题:Indazole Compound And Application Thereof For Preparing Ido Inhibitor Drug 参考文献:China]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Hydroxyamine Hydrochloride,Ammonium Chloride Solvents: Ethanol,Water; 5 Min,Rt1.2 5 Min,Rt; 15 Min,Rt 标题:An Unexpected Formation Of The Novel 7-Oxa-2-Azabicyclo[2.2.1]Hept-5-Ene Skeleton During The Reaction Of Furfurylamine With Maleimides And Their Bioprospection Using A Zebrafish Embryo Model 作者:Puerto Galvis,Carlos E.; Kouznetsov,Vladimir V. 参考文献:Organic & Biomolecular Chemistry 日期:2013 卷标:11(3) 页码:407-411]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Hydroxyamine Hydrochloride Solvents: Ethanol,Pyridine 标题:Highly Efficient And Catalytic Conversion Of Aldoximes To Nitriles 作者:Yang,Soon Ha; Chang,Sukbok 参考文献:Organic Letters 日期:2001 卷标:3(26) 页码:4209-4211]
29601-98-7 = 932-90-1 反应条件:1.1 Reagents: Triethylamine Solvents: (Trifluoromethyl)Benzene; 5 Min,Rt1.2 Reagents: Tempo; 0.5 H,Rt 标题:Metal-Free 2,2,6,6-Tetramethylpiperidin-1-Yloxy Radical (Tempo) Catalyzed Aerobic Oxidation Of Hydroxylamines And Alkoxyamines To Oximes And Oxime Ethers 作者:Wertz,Sebastian; Studer,Armido 参考文献:Helvetica Chimica Acta 日期:2012 卷标:95(10) 页码:1758-1772]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Hydroxide,Hydroxyamine Hydrochloride Solvents: Water; Neutralized1.2 1 H,Rt 标题:Biologically Active Hydroxymoyl Chlorides As Antifungal Agents 作者:Ismail,Tabasum; Shafi,Syed; Singh,Parvinder Pal; Qazi,Naveed Ahmed; Sawant,Sanghapal D.; Et Al 参考文献:Indian Journal Of Chemistry 日期:2008 卷标:(5) 页码:740-747]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Hydroxide,Hydroxyamine Hydrochloride Solvents: Water; Rt -> 0 °C; 20 Min,0 °C1.2 < 0 °C; 2 H,Cooled 标题:Methods Of Using Igf1R And Abl Kinase Modulators For The Treatment Of Cancer,And Use With Other Therapies 参考文献:World Intellectual Property Organization]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Acetate,Hydroxyamine Hydrochloride Solvents: Methanol,Water; 2 H,Rt 标题:The Bioorthogonal Isonitrile-Chlorooxime Ligation 作者:Schafer,Rebecca J. B.; Monaco,Mattia R.; Li,Mao; Tirla,Alina; Rivera-Fuentes,Pablo; Et Al 参考文献:Journal Of The American Chemical Society 日期:2019 卷标:141(47) 页码:18644-18648]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Carbonate,Hydroxyamine Hydrochloride Solvents: Ethanol,Water; 0 °C; 2 H,Rt 标题:Isoxazolyl-Carbonyloxy Azabicyclo[3.2.1]Octanyl Compounds As Fxr Activators And Their Preparation 参考文献:World Intellectual Property Organization]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Carbonate,Hydroxyamine Hydrochloride Solvents: Methanol,Water; Rt; Overnight,Rt 标题:Boronic Acid Mediated Coupling Of Catechols And N-Hydroxylamines: A Bioorthogonal Reaction To Label Peptides 作者:Meadows,Margaret K.; Roesner,Emily K.; Lynch,Vincent M.; James,Tony D.; Anslyn,Eric V. 参考文献:Organic Letters 日期:2017 卷标:19(12) 页码:3179-3182]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Hydroxide,Hydroxyamine Hydrochloride Solvents: Ethanol,Water; Neutralized1.2 20 °C; 1 H,Rt 标题:Synthesis And Characterization Of Para-Substituted N,N'-Dihydroxybenzamidines And Their Derivatives As Model Compounds For A Class Of Prodrugs 作者:Schwarz,Laura; Girreser,Ulrich; Clement,Bernd 参考文献:European Journal Of Organic Chemistry 日期:2014 卷标:2014(9) 页码:1961-1975]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Hydroxyamine Hydrochloride; 10 Min,45 - 50 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water; Rt 标题:Kneading Ball-Milling And Stoichiometric Melts For The Quantitative Derivatization Of Carbonyl Compounds With Gas-Solid Recovery 作者:Mokhtari,Javad; Naimi-Jamal,Mohammad R.; Hamzeali,Hamideh; Dekamin,Mohammad G.; Kaupp,Gerd 参考文献:Chemsuschem 日期:2009 卷标:2(3) 页码:248-254]
100-52-7 = 932-90-1 反应条件:1.1 Reagents: Sodium Carbonate,Hydroxyamine Hydrochloride Solvents: Ethanol,Water; 1 H,60 °C 标题:Synthesis Of Piperazinylalkylisoxazoline Analogs And Their Binding Affinities For Dopamine Receptor Subtypes 作者:Jung,Ji Young; Jung,Sun Ho; Koh,Hun Yeong; Pae,Ae Nim; Park,Woo-Kyu; Et Al 参考文献:Bulletin Of The Korean Chemical Society 日期:2006 卷标:27(11) 页码:1861-1864]
专利号:US-5072056-A 优先权日:1989-09-26 标 题:Synthesis of 2-phenyl-1,3-propanediol 发明人:STIEFEL FRANK J 权利人:CARTER WALLACE 摘要:A novel method of preparing 2-phenyl substituted-1, 3-propanediols, useful intermediates in the synthesis of pharmaceutical preparations is disclosed.
专利号:WO-2023198025-A1 优先权日:2022-04-11 标题:Synthesis method and synthesis device for organic nitrogen-containing compound 发明人:LI GUANGQIN; Liao Peisen; XIAN JIAHUI; LI SUISHENG; ZHANG YAWEI 权利人:UNIV SUN YAT SEN 摘要:The present invention relates to the field of organic synthesis, specifically to a synthesis method and synthesis device for an organic nitrogen-containing compound. Provided in the present invention is a synthesis method for an organic nitrogen-containing compound. In the method provided in the present invention, a porous carbon material is used as a catalyst, organic nitrogen-containing compounds such as an oxime, an amine, a nitrile and an amino acid are synthesized by means of an electro-catalysis method, byproducts are unlikely to generate, and the method is safe and environmentally friendly. Experiments show that organic nitrogen-containing compounds such as an amino acid, an oxime, an amine and a nitrile are successfully synthesized by using the method of the present invention, and the method has good Faraday efficiency and yield. In the present application, the synthesis of the above organic nitrogen-containing compounds can be realized by using nitrogen oxide waste gas or waste water as a raw material; and by converting the nitrogen oxide waste gas or waste water, the utilization of waste is realized, and the benefits are maximized. Further provided in the present invention is a synthesis device for an organic nitrogen-containing compound, which device is used for solving the defects of high energy consumption, long consumption time, and complex product separation and purification of existing synthesis methods.
专利号:US-6225329-B1 优先权日:1998-03-12 标 题 :Modulators of protein tyrosine phosphatases (PTPases) 发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN 权利人:NOVO NORDISK AS 摘要:The present invention provides novel compounds of Formula 1, compositions containing these compounds, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like, n wherein A, R 1 , R 2 , R 3 , R 4 , R 16 and R 17 are as defined in the specification. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.
专利号:WO-9946236-A1 优先权日:1998-03-12 标题 :Modulators of protein tyrosine phosphatases (ptpases) 发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOELLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN 权利人:NOVO NORDISK AS; ONTOGEN CORP 摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.
专利号:EP-1062199-A1 优先权日:1998-03-12 标题 :Modulators of protein tyrosine phosphatases (ptpases) 发明人:RICHTER LUTZ STEFAN; ANDERSEN HENRIK SUNE; VAGNER JOSEF; JEPPESEN CLAUS BEKKER; MOLLER NIELS PETER HUNDAHL; BRANNER SVEN; SU JING; BAKIR FARID; JUDGE LUKE MILBURN 权利人:NOVO NORDISK AS; ONTOGEN CORP 摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPases) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.
专利号:WO-8911473-A1 优先权日:1988-05-27 标 题:Process for the synthesis of o-substituted oxime compounds 发明人:CHEMPOLIL THOMAS MATHEW 权利人:ALLIED SIGNAL INC 摘要:A novel process for the production of O-substituted oximes is disclosed. The process involves reacting an oxime with an alkali-metal hydroxide optionally in a solvent which forms an azeotrope with water to form a mixture of the alkali metal salt of the oxime and water, removing all or a portion of the water by distilling the mixture azeotropically and reacting the distilled mixture with an alpha halo carboxylic acid.
1: Sun GS, Xu X, Jin SH, Lin L, Zhang JJ. Ovicidal and Insecticidal Activities of Pyriproxyfen Derivatives with an Oxime Ester Group. Molecules. 2017 Jun 8;22(6). pii: E958. doi: 10.3390/molecules22060958. doi: 10.1039/c7cc00237h. doi: 10.1021/jf500461a. Epub 2014 Mar 27. doi: 10.1107/S1600536812010732. Epub 2012 Mar 17. 5: Zonouzi A, Mirzazadeh R, Ng SW. (E)-2-Bromo-benzaldehyde oxime. Acta Crystallogr Sect E Struct Rep Online. 2011 Sep 1;67(Pt 9):o2338. doi: 10.1107/S1600536811032211. Epub 2011 Aug 17. 6: Carberry P, Carpenter AP, Kung HF. Fluoride-18 radiolabeling of peptides bearing an aminooxy functional group to a prosthetic ligand via an oxime bond. Bioorg Med Chem Lett. 2011 Dec 1;21(23):6992-5. doi: 10.1016/j.bmcl.2011.09.124. Epub 2011 Oct 5.
合成参考文献
参考文献:10.1007/bf02815202 摘要:Joseph JA, Denisova N, Villalobos-Molina R, Erat S, Strain J. Oxidative stress and age-related neuronal deficits. Molecular and Chemical Neuropathology. 1996 May;28(1-3):35–40. doi: 10.1007/bf02815202. 参考文献:10.1007/128_2011_155 摘要:Aakeröy CB, Epa K. Controlling supramolecular assembly using electronic effects. Top Curr Chem. 2014;351():125–47. doi: 10.1007/128_2011_155.